Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,566 | 4,758 | -1,036 | -5,044 | -34,382 |
| Depreciation Amortization | 15,937 | 11,534 | 7,478 | 4,122 | 19,251 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,126 |
| Accounts receivable | -30,980 | -6,773 | 1,046 | 8,389 | -38,837 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 1,118 |
| Other Working Capital | 14,372 | 28,816 | 21,273 | 15,836 | -36,589 |
| Other Operating Activity | 96,464 | 53,389 | 28,819 | 5,382 | 116,234 |
| Operating Cash Flow | $111,359 | $91,724 | $57,580 | $28,685 | $24,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -163,365 | -115,581 | -76,973 | -14,100 | -263,762 |
| PPE Investments | -14,180 | -8,434 | -5,339 | -3,524 | -27,408 |
| Sale Of Investment | N/A | 23,288 | 20,788 | 11,530 | N/A |
| Purchase Sale Intangibles | -9,331 | -9,331 | -9,331 | N/A | -4,886 |
| Other Investing Activity | -9,331 | -9,331 | -9,331 | 0 | -4,886 |
| Investing Cash Flow | $-186,876 | $-110,058 | $-70,855 | $-6,094 | $-296,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 278,691 |
| Debt Repayment | N/A | N/A | N/A | N/A | -34,069 |
| Common Stock Issued | 51,932 | 36,046 | 17,196 | 3,573 | 69,816 |
| Financing Cash Flow | $51,932 | $36,046 | $17,196 | $3,573 | $314,438 |
| Exchange Rate Effect | 153 | 50 | 44 | 14 | 387 |
| Beginning Cash Position | 94,613 | 94,613 | 94,613 | 94,613 | 51,175 |
| End Cash Position | 71,181 | 112,375 | 98,578 | 120,791 | 94,613 |
| Net Cash Flow | $-23,432 | $17,762 | $3,965 | $26,178 | $43,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | 111,359 | 91,724 | 57,580 | 28,685 | 24,669 |
| Capital Expenditure | -14,180 | -8,434 | -5,339 | -3,524 | -27,408 |
| Free Cash Flow | 97,179 | 83,290 | 52,241 | 25,161 | -2,739 |